Circular RNA regulatory role in pathological cardiac remodelling.

IF 6.8 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Alessia Bibi, Monika Bartekova, Shrey Gandhi, Simona Greco, Alisia Madè, Moumita Sarkar, Victoria Stopa, Spyros Tastsoglou, David de Gonzalo-Calvo, Yvan Devaux, Costanza Emanueli, Artemis G Hatzigeorgiou, A Yaël Nossent, Zhichao Zhou, Fabio Martelli
{"title":"Circular RNA regulatory role in pathological cardiac remodelling.","authors":"Alessia Bibi, Monika Bartekova, Shrey Gandhi, Simona Greco, Alisia Madè, Moumita Sarkar, Victoria Stopa, Spyros Tastsoglou, David de Gonzalo-Calvo, Yvan Devaux, Costanza Emanueli, Artemis G Hatzigeorgiou, A Yaël Nossent, Zhichao Zhou, Fabio Martelli","doi":"10.1111/bph.16434","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiac remodelling involves structural, cellular and molecular alterations in the heart after injury, resulting in progressive loss of heart function and ultimately leading to heart failure. Circular RNAs (circRNAs) are a recently rediscovered class of non-coding RNAs that play regulatory roles in the pathogenesis of cardiovascular diseases, including heart failure. Thus, a more comprehensive understanding of the role of circRNAs in the processes governing cardiac remodelling may set the ground for the development of circRNA-based diagnostic and therapeutic strategies. In this review, the current knowledge about circRNA origin, conservation, characteristics and function is summarized. Bioinformatics and wet-lab methods used in circRNA research are discussed. The regulatory function of circRNAs in cardiac remodelling mechanisms such as cell death, cardiomyocyte hypertrophy, inflammation, fibrosis and metabolism is highlighted. Finally, key challenges and opportunities in circRNA research are discussed, and orientations for future work to address the pharmacological potential of circRNAs in heart failure are proposed.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":6.8000,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bph.16434","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiac remodelling involves structural, cellular and molecular alterations in the heart after injury, resulting in progressive loss of heart function and ultimately leading to heart failure. Circular RNAs (circRNAs) are a recently rediscovered class of non-coding RNAs that play regulatory roles in the pathogenesis of cardiovascular diseases, including heart failure. Thus, a more comprehensive understanding of the role of circRNAs in the processes governing cardiac remodelling may set the ground for the development of circRNA-based diagnostic and therapeutic strategies. In this review, the current knowledge about circRNA origin, conservation, characteristics and function is summarized. Bioinformatics and wet-lab methods used in circRNA research are discussed. The regulatory function of circRNAs in cardiac remodelling mechanisms such as cell death, cardiomyocyte hypertrophy, inflammation, fibrosis and metabolism is highlighted. Finally, key challenges and opportunities in circRNA research are discussed, and orientations for future work to address the pharmacological potential of circRNAs in heart failure are proposed.

环状 RNA 在病理性心脏重塑中的调控作用
心脏重塑涉及心脏受伤后的结构、细胞和分子改变,导致心脏功能逐渐丧失,最终导致心力衰竭。环状 RNA(circRNA)是最近重新发现的一类非编码 RNA,在心血管疾病(包括心力衰竭)的发病机制中发挥调控作用。因此,更全面地了解 circRNA 在心脏重塑过程中的作用,可为开发基于 circRNA 的诊断和治疗策略奠定基础。本综述总结了目前有关 circRNA 起源、保存、特征和功能的知识。讨论了用于 circRNA 研究的生物信息学和湿实验室方法。重点介绍了 circRNA 在细胞死亡、心肌细胞肥大、炎症、纤维化和新陈代谢等心脏重塑机制中的调控功能。最后,讨论了 circRNA 研究的主要挑战和机遇,并提出了未来工作的方向,以探讨 circRNA 在心力衰竭中的药理潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.40
自引率
12.30%
发文量
270
审稿时长
2.0 months
期刊介绍: The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信